YOLFTbeta
SCM Lifescience Co. Ltd

SCM Lifescience Co. Ltd

298060 · KQ · Healthcare / Biotechnology

2,315.00KRW-10.00 (-0.43%)

Price History

Full chart

Market Stats

Previous Close2,325.00
Open2,470.00
Day Range2,265.00 – 2,510.00
52-Week Range2,240.00 – 6,500.00
Volume29.35K
Market Cap22.68B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta0.56
50-Day Avg2,495.40
200-Day Avg3,568.00

About

POONGJEON PHARMACY CO.,LTD. operates as a stem cell therapy company in South Korea. It develops SCM-AGH, a treatment for moderate to severe acute pancreatitis and moderate to severe atopic dermatitis, as well as chronic graft versus host disease; and Iroro Deerscalp, a toothbrush cosmetic for hair loss relief. The company was formerly known as SCM Lifescience Co., Ltd. and change its name to POONGJEON PHARMACY CO.,LTD. in April 2026. The company was incorporated in 2014 and is headquartered in Incheon, South Korea.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOByeong-gwan Son
  • Employees0
  • Headquarters7-7, Gaetbeol-ro 145beon-gil, Incheon, South Korea, 21999, Korea
  • Websitehttps://www.scmlifescience.com

Leadership

  • Byeong-gwan SonCEO & Chairman
  • Mr. Sun-uk SongFounder, CSO & VP
  • Mr. Sukwoo Jeffrey Oh J.D.Chief Operating Officer
  • Jong-cheol LeeExecutive Director
  • Hyeong-nam OhExecutive Director

Financials

Income Statement

Currency: KRW2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue29.64M28.76M168.50M320.01M439.26M395.98M695.70M824.80M23.84B
Growth (%)--2.97%+485.85%+89.92%+37.27%-9.85%+75.69%+18.56%+2790.28%
Cost of Revenue14.98M7.87M38.04M42.87M91.35M220.23M357.00M498.30M19.43B
Gross Profit14.66M20.89M130.46M277.14M347.91M175.75M338.70M326.50M4.41B
Gross Margin49.45%72.63%77.43%86.60%79.20%44.38%48.69%39.59%18.49%
Operating Expense5.33B8.59B12.33B16.33B12.50B12.75B13.34B11.53B8.94B
Operating Income-5.32B-8.57B-12.20B-16.05B-12.15B-12.58B-13.00B-11.20B-4.53B
Operating Margin-17948.34%-29792.04%-7241.70%-5016.75%-2765.67%-3176.64%-1868.29%-1358.18%-19.00%
EBITDA------21.65B-22.81B-11.92B1.69B
EBITDA Margin------5467.59%-3278.64%-1445.11%7.07%
Net Income-1.74B-40.09B-42.55B-9.63B-22.52B-22.93B-23.96B-12.38B202.50M
Net Income Margin-5882.00%-139404.46%-25254.54%-3010.19%-5126.47%-5790.66%-3444.23%-1500.61%0.85%
R&D--6.97B8.85B10.47B9.31B9.31B7.60B1.94B
R&D as % of Total Revenue--4135.31%2764.19%2384.21%2351.45%1338.93%920.93%8.13%
Interest Expense002.63B507.54M197.63M238.79M312.57M259.95M434.96M
Interest Expense % of Total Revenue0.00%0.00%1560.73%158.60%44.99%60.30%44.93%31.52%1.82%

Balance Sheet

Currency: KRW2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets6.44B43.86B41.04B76.29B54.04B33.02B25.40B23.17B51.99B
Total Liabilities15.11B88.46B24.19B13.21B9.43B8.51B4.93B8.99B15.92B
Total Equity-8.67B-44.60B16.85B63.08B44.61B24.51B20.47B14.18B36.07B
Cash2.66B11.41B4.44B77.47M2.89B6.92B4.50B49.59M6.96B
Total Debt8.00B23.22B6.59B6.19B-----
Net Debt--1.62B5.86B2.93B--6.73B-

Cash Flow

Currency: KRW2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-4.99B-6.56B-8.42B-10.89B-13.40B-11.17B-12.14B-10.05B-5.30B
Investing Cash Flow783.38M-28.87B-10.27B-23.66B15.79B14.99B-7.01B2.64B-
Financing Cash Flow88.59M44.18B11.72B30.19B425.29M211.73M16.73B2.96B-
Capital Expenditure282.20M1.09B9.28B1.48B676.00M504.83M243.61M4.38B4.69B
Free Cash Flow---17.48B-12.38B-14.08B-11.68B-12.38B-14.43B-9.99B
FCF to OCF--207.53%113.66%105.04%104.52%102.01%143.56%188.40%

Earnings

Report DateJun 30, 2020Sep 30, 2020Mar 18, 2021May 17, 2021Aug 17, 2021Nov 15, 2021Dec 31, 2021May 16, 2022Aug 12, 2022Nov 11, 2022Mar 21, 2023May 15, 2023Aug 11, 2023Nov 14, 2023Mar 20, 2024May 13, 2024Aug 14, 2024Nov 12, 2024Mar 18, 2025May 14, 2025Aug 12, 2025Oct 29, 2025Mar 19, 2026May 13, 2026Jun 30, 2026
EPS Estimate-------------------------
EPS Actual-3294.73132.78254.19-613.23-230.81-479.89-2059.49-474.34-388.49-474.30-511.76-421.53-383.37-393.15-337.16-157.01-133.05-150.18-177.33-55.540.13-23.7318.18-207.48-446.37
Surprise-------------------------
Timing-------Pre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-market-

Key Statistics & Ratios

Market Cap22.68B
Enterprise Value17.87B
Trailing P/E0.00
Forward P/E0.00
Price / Sales14.70
Price / Book0.67
Revenue (TTM)1.54B
Gross Profit (TTM)518.50M
EBITDA-7.35B
Profit Margin0.00%
Operating Margin-8.23%
Return on Equity-41.87%
Return on Assets-21.08%
Shares Outstanding9.63M
Shares Float534.04K
Beta0.56
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • May 19, 20261:5
  • Sep 15, 20236:5
  • Jul 11, 2023420:373